Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Enbrel etanercept: IMNX began a second Phase III trial of Enbrel in up to 600 patients.

Immunex Corp. (IMNX), Seattle, Wash.

Read the full 59 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE